MedTrace Logo

Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days Gestation

NCT01966874 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1001

Last updated 2013-10-22

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy and acceptability of a regimen of 200 mg mifepristone (Zacafemyl), followed 24-48 hours later by 800 mcg of buccal misoprostol.

Conditions

  • Medical; Abortion, Fetus

Sponsors & Collaborators

  • Secretaria de Salud, Mexico

    collaborator OTHER_GOV

  • Gynuity Health Projects

    lead OTHER

Principal Investigators

  • Beverly Winikoff, MD · Gynuity Health Projects

  • Patricio Sanhueza Smith · Secretaria de Salud, Mexico

  • Maria Laura Garcia · M.I. Inguaran

  • Ana Gabriela Arangure Peraza · C.S. Beatriz Velasco

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01966874 on ClinicalTrials.gov